# FDA 483 - Catalent Indiana, LLC - Unknown Date

Source: https://www.keypedia.com/records/483/catalent-indiana-llc/70255023-0dba-4473-a659-64d38a7df3ea

> FDA 483 for Catalent Indiana, LLC on Unknown Date. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Catalent Indiana, LLC
- Product Type: biologics
- Office Name: Division of Pharmaceutical Quality Operations III
- Summary: This document is a response from Catalent Indiana, LLC in Bloomington, Indiana, to a Form FDA 483 issued following an inspection conducted from August 1 to September 1, 2022. The firm expresses its commitment to full compliance with 21 CFR Part 211 and other relevant regulations, aiming to ensure drug product quality and safety. Specific inspectional observations are not detailed in this response.

## Related Documents

- [483 - 2026-04-13](https://www.keypedia.com/records/483/catalent-indiana-llc/3e26cce0-d3b6-4f13-a425-84ebc5cbf9a8)
- [483 - 2023-11-15](https://www.keypedia.com/records/483/catalent-indiana-llc/a1e8a879-3457-4a45-af4a-6ce304aa7c9e)
- [EIR - 2018-01-19](https://www.keypedia.com/records/eir/catalent-indiana-llc/9f95a6cc-aa76-4e85-9e7d-168b6c74315c)
- [EIR - 2017-05-19](https://www.keypedia.com/records/eir/catalent-indiana-llc/0b121283-25f2-4271-ad8f-7c96adb7a8ff)
- [483 - 2022-09-01](https://www.keypedia.com/records/483/catalent-indiana-llc/8969bc19-cbae-4b6d-82e5-0aef197e9d24)

## Related Officers

- [Investigator](https://www.keypedia.com/people/muna-algharibeh/0f0dbd13-b36a-408d-8e42-4625f8de905d)
- [Eboni Funderburk](https://www.keypedia.com/people/eboni-funderburk/9907e6b1-a396-45b8-b85c-59a451a2cb8d)
- [Investigator ](https://www.keypedia.com/people/logan-t-williams/a1febf59-970a-4e4e-9c0c-f4ad385582d7)
- [Drug National Expert](https://www.keypedia.com/people/sandra-a-boyd/c469103a-0917-407a-b9d1-98273358dfeb)

Company: https://www.keypedia.com/companies/catalent-indiana-llc/3422c8c4-978a-45ba-962b-b00002fffd6d

Office: https://www.keypedia.com/offices/division-of-pharmaceutical-quality-operations-iii/45bc2d0d-d731-4955-aeb5-59aa0b76e4f0